Head of Research and Global Chief Strategist, Steno Research

Andreas Steno

Head of Research and Global Chief Strategist

Macro and Geopolitical Research House

Steno Research

Steno Research is a new macro and geopolitical research house. We are based out of Copenhagen, Denmark, but have an international team and a strong network of sources and partners around the world. The team is lead by Andreas Steno, previous global head of strategy at Nordea Bank, and Mikkel Rosenvold, former chief consultant in the Danish Ministry of Finance.

Macroeconomics

<ul>
<li>These past few weeks have been all about China and China is all about real estate.</li>
<li>With that, welcome to this week’s real estate-focused edition of the ‘Watch Series’, where we look for clues on the state of the US parallel in particular.</li>
<li>Our findings in brief: Favorable fixings counter forced selling, Record low affordability discourages buying, Little volume and stalemate in price, Weakening labor market and layoffs remain THE triggers for potential selloff.</li>
</ul>


These past few weeks have been all about China and China is all about real estate.
With that, welcome to this week’s real estate-focused edition of the ‘Watch Series’, where we look for clues on the state of the US parallel in particular.
Our findings in brief: Favorable fixings counter forced selling, Record low affordability discourages buying, Little volume and stalemate in price, Weakening labor market and layoffs remain THE triggers for potential selloff.


Real Estate Watch: Too Early to Call off the Crisis in Western Markets

Research and consultancy, Tabbush Report

Daniel Tabbush

Research and consultancy

Tabbush Report

We provide research and consultancy on Asian banks. Our focus is on what we call “Asian bank research, without the noise.” We are interested in the most critical swing-factors for banks, the NPL and credit cycle, and where we believe there is a gap between perception and reality. We often focus on the less studied components of bank financial statements.  Our research is highly thematic, sometimes examining unlisted banks and companies as a window on mainstream banks. 

Being independent allows us to look at smaller banks, often overlooked by others. Analysis of BIS bank guidelines in the context of Asia, is also a focal point, while we also analyze global banks operating in the region. We use what we believe is the most comprehensive, reliable financials database, SNL Financial. S&P Capital IQ augments our database, with corporate data and CEIC, with economics. 

Asian bank research, without the noise.

Equity Bottom-Up

<ul>
<li>1Q23 shows strong Value Of New Business (VONB), not sure of profit flow through</li>
<li>Comparative to 1H22 is easy vs loss of USD556m in the period, but risk to downside</li>
<li>Despite, stock buybacks, increased dividends market cap down 34% since peak this year</li>
</ul>


1Q23 shows strong Value Of New Business (VONB), not sure of profit flow through
Comparative to 1H22 is easy vs loss of USD556m in the period, but risk to downside
Despite, stock buybacks, increased dividends market cap down 34% since peak this year


AIA - Results 24 Aug, Cratering Mkt Cap Suggests Malaise, Earnings Base May Be Structurally Lower

Global Multi-Asset Investment Strategist, True Insights

Jeroen Blokland

Global Multi-Asset Investment Strategist

Build Well-Diversified Multi-Asset Portfolios

True Insights

Our research helps investors build well-diversified multi-asset portfolios and profit from market developments. In addition, our unique and proven Macro – Sentiment – Valuation (MSV) investment framework ensures a consistent flow of new investment opportunities. Together with our market views, these opportunities will be reflected in our live ETF-based Global Multi-Asset Portfolios.

Cross Asset Strategy

<ul>
<li>China could become a ‘Credit Event.’ Despite a slew of new stimulus measures by the Chinese government, they are not comprehensive enough to rule out one or more credit events.</li>
<li>200-Day moving averages hit. Several equity market indices have dipped below their 200-day moving average, including the MSCI Emerging Markets Index. </li>
<li>Response to the latest US inflation figure. In contrast to previous favorable inflation figures, American stocks closed lower on the day following the publication.</li>
</ul>


China could become a ‘Credit Event.’ Despite a slew of new stimulus measures by the Chinese government, they are not comprehensive enough to rule out one or more credit events.
200-Day moving averages hit. Several equity market indices have dipped below their 200-day moving average, including the MSCI Emerging Markets Index. 
Response to the latest US inflation figure. In contrast to previous favorable inflation figures, American stocks closed lower on the day following the publication.


Back with a Bang! – Macro and Sentiment Call for an Underweight in Equities

Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>On Friday, Hang Seng Indices announced the changes to the benchmark Hang Seng Index, the index in the family with the largest AUM.</li>
<li>
<a href="https://www.smartkarma.com/entities/sinopharm-group-co-ltd-h" target="_blank" data-smartkarma-citation="entities:32:1" rel="noopener">Sinopharm Group Co Ltd H (1099 HK)</a> is ADDED, <a href="https://www.smartkarma.com/entities/country-garden-holdings-co" target="_blank" data-smartkarma-citation="entities:5225:1" rel="noopener">Country Garden Holdings Co (2007 HK)</a> - in no surprise, is deleted. </li>
<li>I see HK$4bn a side to trade, and the only "compelling" trade by ADV here is Sinopharm, but correlations with a Peer Basket are low.</li>
</ul>


On Friday, Hang Seng Indices announced the changes to the benchmark Hang Seng Index, the index in the family with the largest AUM.

Sinopharm Group Co Ltd H (1099 HK) is ADDED, Country Garden Holdings Co (2007 HK) - in no surprise, is deleted. 
I see HK$4bn a side to trade, and the only "compelling" trade by ADV here is Sinopharm, but correlations with a Peer Basket are low.


HSI Sep23 Index Review/​Flows - Sinopharm (1099) IN, CoGard (2007) OUT; 100 Names a Loooong Way Off

Financial sector veteran, KT Capital Group

Fern Wang

Financial sector veteran

KT Capital Group

Principal investments and advisory firm that focuses on connecting the CIS countries with East Asia.

Principal investments and advisory firm

<ul>
<li>Evergrande's filing in itself does not signify a deterioration in its financials; it was already insolvent as of end 2021.</li>
<li>The bankruptcy filing provides the benefits of automatic stay and is a necessary step to validate the Group's offshore restructuring plan. </li>
<li>Evergrande's long term viability still depends on recovery of the China property market. </li>
</ul>


Evergrande's filing in itself does not signify a deterioration in its financials; it was already insolvent as of end 2021.
The bankruptcy filing provides the benefits of automatic stay and is a necessary step to validate the Group's offshore restructuring plan. 
Evergrande's long term viability still depends on recovery of the China property market. 


Why Evergrande’s Bankruptcy Filing Is a Positive Development

China

Country Garden Holdings Company Limited is a real estate developer.  The Company builds villas, townhouses and apartments in Mainland China. Country Gardens also develops large-scale community facilities such as schools, hotels, hospitals, and theme parks.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Country Garden Holdings Co (2007 HK)

Real Estate Watch: Too Early to Call off the Crisis in Western Markets

These past few weeks have been all about China and China is all about real estate. With that, welcome to this week’s real estate-focused edition...

Steno Research

AIA - Results 24 Aug, Cratering Mkt Cap Suggests Malaise, Earnings Base May Be Structurally Lower

August 24 will see 1H23 earnings release, comparative YoY easy due to losses 1H22, but seems like earnings base is structurally lower. HK, CH...

Daniel Tabbush

Back with a Bang! – Macro and Sentiment Call for an Underweight in Equities

We lower the weight of Emerging and Developed Market Equities on recent developments in China, indices dropping below their 200-day moving...

Jeroen Blokland

HSI Sep23 Index Review/Flows - Sinopharm (1099) IN, CoGard (2007) OUT; 100 Names a Loooong Way Off

The Hang Seng Index Sep 2023 review is a little disappointing. The DELETE is obvious. The ADD wasn't so much. And Hang Seng is highly...

Travis Lundy

Why Evergrande’s Bankruptcy Filing Is a Positive Development

Evergrande's bankruptcy petition is a positive development for its long negotiated restructuring plan, providing temporary protection against...

Fern Wang

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Real Estate Watch: Too Early to Call off the Crisis in Western Markets

These past few weeks have been all about China and China is all about real estate. With that, welcome to this week’s real estate-focused edition...

Steno Research

AIA - Results 24 Aug, Cratering Mkt Cap Suggests Malaise, Earnings Base May Be Structurally Lower

August 24 will see 1H23 earnings release, comparative YoY easy due to losses 1H22, but seems like earnings base is structurally lower. HK, CH...

Daniel Tabbush

Back with a Bang! – Macro and Sentiment Call for an Underweight in Equities

We lower the weight of Emerging and Developed Market Equities on recent developments in China, indices dropping below their 200-day moving...

Jeroen Blokland

HSI Sep23 Index Review/​Flows - Sinopharm (1099) IN, CoGard (2007) OUT; 100 Names a Loooong Way Off

The Hang Seng Index Sep 2023 review is a little disappointing. The DELETE is obvious. The ADD wasn't so much. And Hang Seng is highly...

Travis Lundy

Why Evergrande’s Bankruptcy Filing Is a Positive Development

Evergrande's bankruptcy petition is a positive development for its long negotiated restructuring plan, providing temporary protection against...

Fern Wang

HSI Sep23 Index Review/Flows - Sinopharm (1099) IN, CoGard (2007) OUT; 100 Names a Loooong Way Off